Mitsunobu Tanaka
Overview
Explore the profile of Mitsunobu Tanaka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saino O, Ogawa Y, Yasui K, Fuchizaki A, Akamatsu R, Irie Y, et al.
Life (Basel)
. 2025 Feb;
15(2).
PMID: 40003604
The efficacy of hematopoietic stem cell (HSC) therapy for cerebral infarction has been previously demonstrated. However, the lack of response in some patients has hindered its widespread use. To establish...
2.
Fuchizaki A, Yasui K, Hayashi T, Tanaka M, Oyamada C, Ohnishi-Wada T, et al.
Vox Sang
. 2024 May;
119(8):883-887.
PMID: 38785048
Background And Objectives: The total thrombus-formation analysis system (T-TAS) can quantitatively analyse the contribution of platelets to haemostasis using reconstituted blood samples. However, it is unsuitable in cases with low...
3.
Yasui K, Ogawa Y, Saino O, Akamatsu R, Fuchizaki A, Irie Y, et al.
Sci Rep
. 2024 Mar;
14(1):6907.
PMID: 38519559
Although regenerative therapy with stem cells is believed to be affected by their proliferation and differentiation potential, there is insufficient evidence regarding the molecular and cellular mechanisms underlying this regenerative...
4.
Toyoda Y, Matsuo H, Tanaka M, Stiburkova B, Takada T
Transfusion
. 2024 Feb;
64(2):412-414.
PMID: 38379528
No abstract available.
5.
Fuchizaki A, Yasui K, Hayashi T, Tanaka M, Nagasato T, Ohnishi-Wada T, et al.
Vox Sang
. 2023 Mar;
118(5):367-375.
PMID: 36862116
Background And Objectives: Currently, the quality of platelet (PLT) products is evaluated using a series of in vitro tests, which only analyse PLTs as an inspection material. However, it would...
6.
Ogawa Y, Akamatsu R, Fuchizaki A, Yasui K, Saino O, Tanaka M, et al.
Cell Transplant
. 2022 Nov;
31:9636897221136151.
PMID: 36401520
We have previously demonstrated that small molecular transfer, such as glucose, between hematopoietic stem cells (HSCs) or mesenchymal stem cells (MSCs) and vascular endothelial cells via gap junctions constitutes an...
7.
Sugimoto N, Nakamura S, Shimizu S, Shigemasa A, Kanda J, Matsuyama N, et al.
Blood Adv
. 2022 Sep;
6(23):6056-6069.
PMID: 36149941
Donor-derived platelets are used to treat or prevent hemorrhage in patients with thrombocytopenia. However, ∼5% or more of these patients are complicated with alloimmune platelet transfusion refractoriness (allo-PTR) due to...
8.
Mitsuhashi H, Ochi Y, Fuchizaki A, Ooba R, Hayashi T, Horie Y, et al.
Transfusion
. 2022 Sep;
62(11):2262-2270.
PMID: 36148524
Background: Washed platelet concentrates (WPC), prepared with an automated system cell processor (ACP), have recently been approved to be manufactured and marketed in Japan. From the perspective of risk management,...
9.
Sugimoto N, Kanda J, Nakamura S, Kitano T, Hishizawa M, Kondo T, et al.
Blood
. 2022 Sep;
140(22):2398-2402.
PMID: 36112961
No abstract available.
10.
Fuchizaki A, Yasui K, Tanaka M, Mitsuhashi H, Shimogaki K, Kimura T, et al.
Vox Sang
. 2022 Mar;
117(6):812-821.
PMID: 35262934
Background And Objectives: Frozen-thawed red blood cells (FTRCs) are useful blood components to patients with rare blood phenotypes. However, frozen red blood cells (FRCs) sometimes cause significant haemolysis after thawing...